Session: C4: Moving Quality to the Next Level: "What Would it Take?"

Live Q&A (C4)

Wednesday, September 29, 2021

12:38 – 13:15 EDT

This session will explore innovative ways to continuously improve quality for the future. We will learn the benefits of tools/techniques that go beyond traditional key performance indicator (KPI) monitoring to exploring ways that provide predictive/leading metrics to better understand an organization’s risk profile. This session will provide insights and case studies from industry speakers on the opportunities and challenges with implementing digitalization within their firms.

A review of how innovation/digitalization is transforming the traditional ways of working in pharmaceutical manufacturing and testing will be explained. How are companies incorporating such innovation into their quality management system (QMS), and achieving increased productivity and simplified compliance? How do companies embed innovative objectives into their Quality Improvement Plans and quality objectives to effectively be able to respond to problems as they occur or even prior to via predictive measures?

Moderator(s)

Mike G. Labruto, MS

Executive Director
University of Pennsylvania/Gene Therapy Program
Philadelphia, Pennsylvania, United States

Panelist(s)

Jeff J. Bedford

Director, R&D Quality Futures
GlaxoSmithKline
Collegeville, Pennsylvania, United States
Ravi Yalamanchili, MS, MBA

Executive Director Global Quality
Merck & Co., Inc.
West Point, Pennsylvania, United States